Hims & Hers stock drops after Wegovy manufacturer ends deal to distribute weight loss drug - Hims & Hers had partnered with ...

The increasing demand for weight-loss jabs such as Mounjaro and Wegovy has helped sales at the firm behind Chemist4U almost ...

Hims & Hers stock has fallen nearly 30% on Monday after Novo Nordisk announced it is ending its collaboration with the telehealth company, saying they sell knock-off ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 29.2% in the morning session after Novo Nordisk, the maker ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

Amanda Bynes is starting a weight loss journey and turning to Ozempic for help. In a video shared to her Instagram Stories on ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

A weight loss drug called Mounjaro is now available on prescription at GP surgeries in England – but there are some strict ...

Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...

Hims & Hers Health Inc.’s stock fell sharply on Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug ...

Novo Nordisk ends partnership with Hims & Hers over safety and marketing concerns tied to compounded Wegovy, as rivalry with ...

Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, ...